Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Fractalkine in type 2 Egyptian diabetics with and without nephropathy

The Egyptian Journal of Internal Medicine volume 25, pages 133–136 (2013)Cite this article

Abstract

Background

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Diabetic nephropathy is the major microvascular complication of diabetes mellitus; one of the earliest clinical signs of diabetic nephropathy is an elevated urinary albumin excretion (UAE), referred to as microalbuminuria. Fractalkine is a large cytokine protein of 373 amino acids; it contains multiple domains. Fractalkine (CX3CL1) is a unique chemokine and the only representative of the CX3C group. It exists as a membrane-bound and soluble form. It interacts with cells expressing CX3CR1, a G-coupled protein receptor. It is also commonly known by the names fractalkine (in humans) and neurotactin (in mice).

Aim

Our study aimed to assess fractalkine levels in type 2 Egyptian diabetic patients with and without diabetic nephropathy and its role as a marker in the development of diabetic nephropathy.

Patients and methods

Our study was carried out on 75 individuals: 25 controls, 25 type 2 diabetic patients without diabetic nephropathy, and 25 type 2 diabetic patients with diabetic nephropathy. These patients were subjected to a full laboratory workup including fasting and postprandial blood glucose, glycated hemoglobin A1C, serum urea and creatinine, 24-h UAE, and fractalkine level.

Results and conclusion

Our study showed that the serum fractalkine concentration was significantly elevated in type 2 diabetic patients with nephropathy (1153.14±261.1) compared with type 2 diabetic patients without nephropathy (705.78±150.59) and the control group (251.5±64) (both P=0.000). There was a significant correlation between serum fractalkine level and 24-h UAE, HBA1C, and serum creatinine. Thus, this positive correlation between serum fractalkine level and UAE could be an early predictor of microvascular complications in diabetic patients. We can conclude that serum fractalkine plays a pathogenic role in the development of diabetic nephropathy.

References

  1. Wold LE, Ceylan Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 2005; 26: 908–917.

    Article  CAS  Google Scholar 

  2. American Diabetes Association. Standards of medical care in diabetes– 2008. Diabetes Care 2008; 31 (Suppl 1): S12–S54.

    Article  Google Scholar 

  3. Buse PE. Type 1 diabetes mellitus. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, editors. Kronenberg: Williams textbook of endocrinology. 11th ed. Philadelphia, Pa: Saunders, Elsevier; 2008.

  4. Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention and treatment. Diabetes Care 2005; 28: 164–176.

    Article  Google Scholar 

  5. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640–642.

    Article  CAS  Google Scholar 

  6. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 2003; 111: 1241–1250.

    Article  CAS  Google Scholar 

  7. Haskell CA, Cleary MD, Charo IF. Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J Biol Chem 2000; 275: 34183–34189.

    CAS  PubMed  Google Scholar 

  8. Kikuchi Y, Nonoguchi H, Machida K, Wakamatsu S, Koga H, Tomita K. Regulation of the apoptosis-related genes, Bax and Bcl-2, in the early stage of diabetes mellitus. Nephrology 2002; 7: 294–302.

    Article  CAS  Google Scholar 

  9. Kikuchi Y, Ikee R, Hemmi N, Hyodo N, Saigusa T, Namikoshi T, et al. Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin- induced diabetic kidneys. Nephron Exp Nephrol 2004; 97: e17–e25.

    Article  CAS  Google Scholar 

  10. Jerath M, Kwan M, Liu P. Chemokine receptors. In: Harrison JK, Lukacs NW, editors. Atherosclerosis: the receptors, the chemokine receptors. Totowa, NJ: Humana Press Inc.; 2007. pp. 199–233.

  11. Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 34–40.

    Article  CAS  Google Scholar 

  12. Lan NP. Atkins: macrophages in immune renal injury. In: Nielson EG, Couser WG, editors. Immunologic renal disease. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 609.

  13. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611–617.

    Article  CAS  Google Scholar 

  14. Kim M, Carman CV, Springer TA. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003; 301: 1720–1725.

    Article  CAS  Google Scholar 

  15. Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, Taniguchi K, et al. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 2878–2883.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Internal Medicine, Diabetes & Endocrinology and Faculty of Medicine, Cairo University, 3 Abou-elnaga St., Madkour, Faisal, Giza, Cairo, Egypt

    Ebtissam Zakaria, Hoda Al-Rawi, Nashwa S. Ghanem & Naglaa M. Elsayed

  2. Departments of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo, Egypt

    Laila A. Rashed

Authors
  1. Ebtissam Zakaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hoda Al-Rawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nashwa S. Ghanem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naglaa M. Elsayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laila A. Rashed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naglaa M. Elsayed.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zakaria, E., Al-Rawi, H., Ghanem, N.S. et al. Fractalkine in type 2 Egyptian diabetics with and without nephropathy. Egypt J Intern Med 25, 133–136 (2013). https://doi.org/10.7123/01.EJIM.0000432173.94048.48

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.7123/01.EJIM.0000432173.94048.48

Keywords